The joint venture brings together two highly complementary businesses with a shared commitment to quality, innovation, and sustainable growth. HOCHDORF contributes its expertise in infant nutrition manufacturing, access to high-quality fresh Swiss milk, advanced production capabilities, and technical know-how. Pharmalys contributes its trusted international brands, extensive distribution network, strong commercial presence across more than 40 countries, and a medical detailing force of over 1,200 representatives supporting healthcare professionals worldwide.
For Pharmalys, this partnership represents a major step toward vertical integration by securing long-term access to premium Swiss milk, strengthening production capacity, and enhancing supply chain resilience. This integrated platform will enable Pharmalys to better serve growing global demand and ensure the availability of premium Swiss infant formula for families worldwide.
Through the joint venture, key activities—including infant nutrition brands, intellectual property, technical know-how, and manufacturing expertise—will be brought together within HOCHDORF Laboratories SA, creating a stronger platform for operational excellence, accelerated innovation, and international growth.
With a presence across more than 40 countries, Pharmalys has established itself as a trusted partner in premium infant nutrition. The joint venture further strengthens its ability to combine Swiss manufacturing excellence with global market access, delivering nutritional solutions that meet the highest standards of quality, safety, and innovation.
“This joint venture represents a significant milestone in Pharmalys’ journey and reflects our ambition to build a stronger, more integrated platform for premium infant nutrition. By securing access to Swiss manufacturing capabilities and production capacity, we are strengthening our ability to serve families worldwide with trusted, high-quality products,” said Amir Mechria, Chairman of the Board of Pharmalys Laboratories.
“We are proud to support this strategic partnership, which brings together complementary capabilities and creates a strong foundation for long-term value creation. This collaboration reflects our commitment to supporting businesses with clear growth ambitions and strong market opportunities,” said Andreas Schulte, Founder and Managing Partner of AS Equity Partners.
Together, Pharmalys Laboratories and HOCHDORF Swiss Nutrition are building a stronger Swiss platform for premium infant nutrition—connecting trusted brands, manufacturing expertise, secure supply, and global market reach to better serve partners, healthcare professionals, and families worldwide.
